A new Goldman Sachs forecast highlights the scale of the buildout. The more useful test is whether new computing demand brings reliable electricity, workable connections and fair terms for the people sharing the grid.
A promising molecule still needs a path through studies, manufacturing and human decisions. OpenAI’s latest acquisition targets the coordination behind that journey.
Anthropic reports 17 protein designs that met its binding criteria. The hopeful story is what researchers can investigate next, not a treatment that already exists.
At GTC Berlin, NVIDIA laid out a range of computers and software for running AI closer to the people using it, from Windows laptops to team-scale workstations. The appealing idea is more control over where data goes and how AI tools work. The test is whether local AI becomes useful and manageable beyond a premium-hardware demo.
Google has added a gentler warning for suspicious sites, broadened AI-assisted scam checks, and started flagging dangerous copy-and-paste traps. The promise lies in interrupting a mistake at the right moment, not in declaring the web safe.
Claude-assisted research led to a real OpenSSH change: check whether a key type is allowed before doing more work on it. The bigger lesson is about reducing the routes attackers can take, while letting maintainers judge the evidence.
UW Medicine and NVIDIA have released a protein-design model with code, weights and experimental findings. The opportunity is to help more researchers test useful ideas—with clear limits on what the early evidence establishes.
A new research preview points toward AI that notices unfinished business and prepares the next step. The useful test is whether it gives people back attention while keeping them in control.
Bank-data incidents, unvetted financial agents, precautionary website shutdowns and a cloud power failure are different stories. Separating the evidence shows what needs fixing—and where AI is helping defenders.
Hugging Face’s open model connects genetic sequences with conversational AI. Early benchmarks suggest a cheaper, locally run research tool, while its biological claims still need careful checking.
The S-1 reports positive first-half operating cash alongside a large net loss. Understanding the difference is essential to reading the business behind Claude.
Claude’s customers can change their usage quickly. The infrastructure behind it requires commitments that can last years. Anthropic’s S-1 shows both sides of that mismatch.
The filing describes real evaluation incidents, suspended tests and a month-plus training delay. What happened, what the company changed, and what remains unknown.
The proposed IPO gives public investors economic ownership, founders a majority of general voting power, and the Long-Term Benefit Trust a separate route to board control.
AI-generated work on waves, algorithms and particle theories could have far-reaching implications. Public proof materials make two claims inspectable; a third awaits a physics group’s write-up. None should yet be framed as a settled breakthrough.
Its IPO filing describes dangerous capabilities, real failures and a possible future in which safety work cannot keep pace. Those are different kinds of evidence.